1) Ahmed, S. M., Hall, A. J., Robinson, A. E., Verhoef, L., Premkumar, P., et al.: Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. Lancet Infect. Dis., 14, 725-730 (2014).
2) Alkan, F., Karayel, I., Catella, C., Bodnar, L., Lanave, G., et al.: Identification of a Bovine Enteric Calicivirus, Kirklareli Virus, Distantly Related to Neboviruses, in Calves with Enteritis in Turkey. J. Clin. Microbiol., 53, 3614-3617 (2015).
3) Atmar, R. L., Bernstein, D. I., Harro, C. D., Al-Ibrahim, M. S., Chen, W. H., et al.: Norovirus Vaccine against Experimental Human Norwalk Virus Illness. New Engl. J. Med., 365, 2178-2187 (2011).
4) Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, et al.: Determination of the 50% human infectious dose for Norwalk virus. J. Infect. Dis., 209, 1016-1022 (2014).
5) Ayukekbong, J.A., Fobisong, C., Tah, F., Lindh, M., Nkuo-Akenji, T. and Bergstrom, T.: Pattern of circulation of norovirus GII strains during natural infection. J. Clin. Microbiol., 52, 4253-4259 (2014).